Discover the most recent news about our Company.
A recent study published in Lipids in Health and Disease (Santisteban et al., 2025) offers a new perspective on how
Gut microbiota and metabolism associated with CAR-T therapy response in multiple myeloma A recent work published by Mireia
Triglycerides: More Than a Marker — A Driver of Cardiovascular Risk Introduction: The Residual Risk Beyond LDL Cholesterol
ASCAHIFA and Biosfer Teslab join forces to advance the diagnosis of familial hypercholesterolemia with Liposcale® On September 24, we celebrate
The Challenge of Residual Risk in Cardiovascular Health Cardiovascular diseases remain the leading cause of death worldwide.Despite preventive
In biomedical research, animal models represent a fundamental tool for understanding the pathophysiological mechanisms of human diseases and
Each year, cardiovascular diseases (CVD) are responsible for more than 4 million deaths in Europe, making them the leading
Each year, cardiovascular diseases (CVD) are responsible for more than 4 million deaths in Europe, making them the leading
New Findings in DLBCL Research Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma.
Obesity, a complex and multifactorial disease, currently affects more than 13% of adults worldwide, according to the latest
We Drive Our International Expansion with the Support of ACCIÓ At Biosfer Teslab, we continue to expand our international presence
Nuclear magnetic resonance (NMR) is an advanced technology that allows the analysis of various biological matrices, from blood
